ICM
ASH icon

Invenomic Capital Management’s Ashland ASH Stock Holding History

Invenomic Capital Management’s Portfolio ASH Stock Details ASH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-147,482
Closed -$7.07M – 150
2025
Q3 		$7.07M Buy
147,482
+71,044
+93% +$3.73M 0.34% 84
2025
Q2 		$3.84M Buy
+76,438
New +$3.89M 0.22% 112

Other funds holding ASH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return

Invenomic Capital Management's ASH Position: Q4 2025 in Review

Invenomic Capital Management sold out of Ashland (ASH) in Q4 2025, closing a stake of 147,482 shares — an estimated $7.07M sold.

Invenomic Capital Management first reported a position in ASH in Q2 2025 and held it in 2 quarters. The position peaked at $7.07M in Q3 2025. 334 funds tracked by Wall St. Rank hold ASH as of Q4 2025.

  • Invenomic Capital Management reported no remaining Ashland position as of Q4 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 147,482 Ashland shares in Q4 2025, an estimated $7.07M.
  • Invenomic Capital Management first reported a position in Ashland in Q2 2025 and held it in 2 quarters.
  • Invenomic Capital Management's Ashland position peaked at $7.07M in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Ashland as of Q4 2025.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.